JavaScript is disabled for your browser. Some features of this site may not work without it.
The Canadian regulatory process for plants with novel traits
dc.contributor.author | McAllister, Patricia | |
dc.date.accessioned | 2017-06-08T17:34:43Z | |
dc.date.available | 2017-06-08T17:34:43Z | |
dc.date.issued | 2013 | |
dc.identifier.uri | https://hdl.handle.net/1813/51407 | |
dc.description.abstract | Canada’s regulations are product-based, not process-based. We have authority within the regulations for departments to approve products derived from biotechnology after the completion of the required safety reviews, and—once authorized—products of biotechnology are not treated differently from other foods, feeds or crops. | |
dc.language.iso | en_US | |
dc.publisher | NABC | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Agricultural biotechnology | |
dc.subject | specialty crops | |
dc.subject | transgenic papaya | |
dc.subject | stakeholders | |
dc.subject | genetic engineering | |
dc.subject | GE | |
dc.subject | GMO | |
dc.subject | regulation | |
dc.subject | food safety | |
dc.subject | USDA | |
dc.subject | novel traits | |
dc.subject | premarket approval | |
dc.subject | intellectual property | |
dc.subject | patents | |
dc.subject | human health impacts | |
dc.subject | synthetic genomics | |
dc.title | The Canadian regulatory process for plants with novel traits | |
dc.type | book chapter |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International